II
PGEN icon

Inspire Investing’s Precigen PGEN Stock Holding History

Inspire Investing’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680K Sell
119,248
-16,874
-12% -$72.9K 0.03% 720
2026
Q1 		$527K Buy
136,122
+25,725
+23% +$106K 0.03% 470
2025
Q4 		$461K Sell
110,397
-23,829
-18% -$92.2K 0.04% 726
2025
Q3 		$442K Sell
134,226
-141,644
-51% -$400K 0.04% 735
2025
Q2 		$392K Buy
275,870
+40,758
+17% +$57.9K 0.04% 439
2025
Q1 		$350K Buy
+235,112
New +$370K 0.04% 342
2023
Q1 		– Sell
-24,006
Closed -$36.5K – 793
2022
Q4 		$36.5K Sell
24,006
-4,923
-17% -$8.47K ﹤0.01% 740
2022
Q3 		$61K Buy
28,929
+2,759
+11% +$5.82K 0.01% 753
2022
Q2 		$35K Buy
26,170
+9,554
+57% +$14.2K ﹤0.01% 762
2022
Q1 		$35K Buy
16,616
+5,321
+47% +$13K ﹤0.01% 787
2021
Q4 		$42K Buy
+11,295
New +$48.6K ﹤0.01% 785
2020
Q4 		– Sell
-12,181
Closed -$43K – 667
2020
Q3 		$43K Buy
12,181
+868
+8% +$4.12K 0.01% 431
2020
Q2 		$56K Buy
11,313
+2,654
+31% +$9.03K 0.02% 483
2020
Q1 		$29K Buy
+8,659
New +$37.4K 0.01% 616
2018
Q1 		– Sell
-39
Closed – – 560
2017
Q4 		$0 Buy
+39
New +$581 ﹤0.01% 926

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Inspire Investing's PGEN Position: Q2 2026 in Review

Inspire Investing reduced its Precigen (PGEN) stake by 12% in Q2 2026, selling an estimated $72.9K and leaving 119,248 shares worth $680K. The position accounts for 0.03% of the portfolio, ranked #720.

Inspire Investing first reported a position in PGEN in Q4 2017 and has held it in 15 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Inspire Investing held 119,248 shares of Precigen worth $680K as of Q2 2026.
  • Inspire Investing sold 16,874 Precigen shares in Q2 2026, an estimated $72.9K.
  • Precigen made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #720 holding.
  • Inspire Investing first reported a position in Precigen in Q4 2017 and has held it in 15 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.